Fierce Biotech December 4, 2023
Conor Hale

After going through a company split earlier this year, PerkinElmer has found a new dance partner—a match orchestrated by its corporate owner, the private equity firm New Mountain Capital.

New Mountain had acquired the science, food safety and lab supply businesses from the company formerly known as PerkinElmer, along with its nearly century-old brand name, through a $2.45 billion deal this past March.

What remained of the previous company—namely its diagnostics, medtech and biopharma R&D divisions—officially took on a new shade of yellow two months later and currently lives under the title Revvity.

Now New Mountain is looking to collate their investments. PerkinElmer has acquired another company in which the firm holds a majority stake: Covaris, the maker...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
What type of Healthcare Cybersecurity companies are being funded and acquired in 2025?
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
Private equity firms vying to acquire RCM co. AGS Health: Report
PE acquisitions drive physician turnover, study finds
Oxford Senior Living Turns to Improvement After Life Plan Community Acquisition

Share This Article